Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Sun Pharmaceuticals
Ownership Structure: publicly traded
Headquartered in: India
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $1,394,461,685
Number of records: 21
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| competition-related offenses | $621,550,000 | 9 |
| safety-related offenses | $502,328,185 | 5 |
| government-contracting-related offenses | $270,575,000 | 6 |
| environment-related offenses | $8,500 | 1 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| price-fixing or anti-competitive practices | $621,550,000 | 9 |
| drug or medical equipment safety violation | $502,300,000 | 3 |
| False Claims Act and related | $270,575,000 | 6 |
| workplace safety or health violation | $28,185 | 2 |
| environmental violation | $8,500 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency  | Penalty Amount |
| Mutual Pharmaceutical Company, Inc. | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $36,500,000 |
| Mutual Pharmaceutical Company, Inc. | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $2,000,000 |
| Mutual Pharmaceutical Company, Inc. | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
| Ranbaxy Laboratories Ltd. | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $3,500,000 |
| Ranbaxy, Inc. | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $485,000,000 |
| Sun Pharmaceuticals Industries Ltd | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
| Sun Pharmaceuticals Industries Ltd | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
| Taro Pharmaceutical USA Inc. | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
| DUSA Pharmaceuticals, Inc. | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
| Taro Pharmaceuticals USA, Inc. | False Claims Act and related | 2021 | DOJ_CIVIL | $213,200,000 |
| Ranbaxy USA Inc. | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
| Ranbaxy | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Taro Pharmaceutical Industries | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Ranbaxy | drug or medical equipment safety violation | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
| Ranbaxy Pharmaceuticals, Inc. | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
| Ranbaxy Laboratories | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | workplace safety or health violation | 2016 | OSHA | $9,620 |
| TARO PHARMACEUTICALS USA, INC. | workplace safety or health violation | 2019 | OSHA | $18,565 |
| MUTUAL PHARMACEUTICAL CO INC | environmental violation | 2012 | PA-ENV | $8,500 |
| Ranbaxy Pharmaceuticals, Inc. et al. | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
| Taro Pharmaceuticals USA, Inc. | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
